Cocrystal Pharma Announces Nasdaq Closing Bell Ceremony
June 04, 2018 08:00 ET
|
Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, June 04, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and...
Cocrystal Pharma Receives FDA Clearance to Initiate Phase 2a Clinical Study Evaluating CC-31244 for the Treatment of Hepatitis C Virus
April 03, 2018 08:00 ET
|
Cocrystal Pharma, Inc.
– Company on track to commence patient enrollment and dosing in Q2 2018 – – Topline data from Phase 2a study expected in Q4 2018 – ATLANTA, GA and BOTHELL, WA, April 03,...
MabVax Therapeutics Catches Eye of Billionaire Investor Dr. Phillip Frost and OPKO Health
April 08, 2015 08:30 ET
|
MabVax Therapeutics, Inc.
NEW YORK, NY--(Marketwired - April 08, 2015) - Investors at MabVax Therapeutics (OTCQB: MBVX) must feel like they're in just the right place at just the right time this week as news of billionaire...